|
⚲
|
| Keyboard |
| Eidos Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001731831 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001731831] | |
| 10-Q | [0001731831] | |
| 3 | [0001731831] | |
| 4 | [0001731831] | |
| 5 | [0001731831] | |
| 8-K | [0001731831] | |
| D | [0001731831] | |
| SC 13D | [0001731831] | |
| SC 13G | [0001731831] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Eidos Therapeutics Inc | Bridgebio Pharma Inc | [2020-10-15] |
| Bridgebio Pharma LLC | Eidos Therapeutics Inc | [2018-08-01] |
| Viking Global Investors LP | Eidos Therapeutics Inc | [2018-07-02] |
| RA Capital Management LLC | Eidos Therapeutics Inc | [2018-07-02] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 21,528 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 21,528 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 43,056 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 60,000 | ||
|
Eidos Therapeutics Inc EIDX
Common Stock
|
2021-01-26 | Tender | 303,525 | ||
|
Eidos Therapeutics Inc EIDX
Common Stock
|
2021-01-26 | Buy | 14,428,836 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 24,350 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 9,469 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 53,157 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 43,056 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 21,528 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 21,528 | ||
|
Eidos Therapeutics Inc EIDX
Common Stock
|
2021-01-26 | Tender | 50,699 | ||
|
Eidos Therapeutics Inc EIDX
Common Stock
|
2021-01-26 | Tender | 380,467 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 21,447 | ||
|
Eidos Therapeutics Inc EIDX
Restricted Stock Units · derivative
|
2021-01-26 | Disposed to issuer | 4,526 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 70,000 | ||
|
Eidos Therapeutics Inc EIDX
Restricted Stock Units · derivative
|
2021-01-26 | Disposed to issuer | 4,526 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 21,447 | ||
|
Eidos Therapeutics Inc EIDX
Common Stock
|
2021-01-13 | Sell | 300 | $126.39 | 37,917 |
| showing 20 of 200 most recent transactions | |||||